OMB

Senator Franken Supports Bloomberg’s Battle Against Comcast

Senator Franken Supports Bloomberg’s Battle Against Comcast

The FCC considers whether the cable provider is favoring its own news channels.

FINRA Executive Compensation Challenged by Member Firms

FINRA Executive Compensation Challenged by Member Firms

Recent report details last year’s compensation.

Congress Needs Its Own Regulatory Review Office

Congress Needs Its Own Regulatory Review Office

OIRA oversight of regulation is necessary, but not sufficient.

Expand Centralized Regulatory Review to Independent Agencies

Expand Centralized Regulatory Review to Independent Agencies

Congress should require independent regulatory commissions to perform cost-benefit analyses

New York Recommends Expansion of Fracking

New York Recommends Expansion of Fracking

NY department advocates ending gubernatorial moratorium on fracking.

Senate Committee Continues Review of Regulatory Reform Bills

Senate Committee Continues Review of Regulatory Reform Bills

Two former OIRA Administrators testify at hearing.

Rulemakings at the Fed, CFPB Need White House Supervision

Rulemakings at the Fed, CFPB Need White House Supervision

After Dodd-Frank, financial regulations of independent agencies should be subject to OIRA review.

House Hearing on Efforts to Confront Alzheimer’s Disease

House Hearing on Efforts to Confront Alzheimer’s Disease

Hearing discusses how to address potential global crisis.

Prospects for Regulatory Reform

Prospects for Regulatory Reform

Congress should use a rare political moment to improve the U.S. regulatory process.

Gainful Employment Rule Hurts College Students and Schools

Gainful Employment Rule Hurts College Students and Schools

New Department of Education rule places excessive restrictions on federal funding for higher education.

Senate Committee Hears Regulatory Reform Testimony

Senate Committee Hears Regulatory Reform Testimony

Senators challenge Cass Sunstein on agency reform and legislative oversight.

White House Offers Guidance on Nanotechnology Policy

White House Offers Guidance on Nanotechnology Policy

EPA, FDA respond with calls for public comments.